Advanced Biomedical Technologies Stock

Advanced Biomedical Technologies Liabilities

The The Liabilities of Advanced Biomedical Technologies (ABMT) as of Aug 6, 2026 is 7.87 M USD. In the previous year, The Liabilities was 6.70 M USD — a change of 17.54% (higher).

Liabilities

7.87 MUSD

YoY

17.54%

Last updated:

In 2026, Advanced Biomedical Technologies's total liabilities amounted to 7.87 M USD, a 17.54% difference from the 6.70 M USD total liabilities in the previous year.

Access this data via the Eulerpool API

Advanced Biomedical Technologies Stock analysis

What does Advanced Biomedical Technologies do? Advanced Biomedical Technologies Inc is an innovative biomedical company specializing in the development of advanced medical devices and technologies. The company was founded in 1985 by an experienced team of biotech experts and is headquartered in California, USA. History: The company's roots lie in the research and development of novel medical implants and prosthetics. However, over the years, the company has quickly evolved into a leading provider of medical devices and technologies in the fields of diagnostics, therapy, and care. Business model: The business model of Advanced Biomedical Technologies Inc is focused on providing innovative and advanced solutions for medical care. The company strives to continuously develop its products and help customers achieve their healthcare goals. Divisions: The company is divided into four main divisions focusing on different medical areas: 1) Interventional Cardiology: Here, the company develops devices for the treatment of heart diseases, such as stents for reopening narrowed vessels. 2) Orthopedics: Another focus is on the development of innovative orthopedic implants and prosthetics that help patients regain their mobility and improve their quality of life. 3) Oncology: In this division, the company works on the development of medical devices and systems for the diagnosis and treatment of cancer. 4) Neurology: Here, the company focuses on the development of medical technologies and devices for the diagnosis and treatment of nervous system disorders, such as Parkinson's or Alzheimer's. Products: Advanced Biomedical Technologies Inc's products include a variety of medical devices and technologies specialized in different medical areas. Some of the company's most well-known products are: - Stents for reopening narrowed vessels in the heart - Artificial joints and implants for restoring mobility and quality of life - Medical devices for the diagnosis and treatment of cancer - Neurostimulation devices for the treatment of chronic pain and other neurological disorders - Robot-assisted surgery systems that assist surgeons in complex procedures. Conclusion: Advanced Biomedical Technologies Inc is a leading biomedical company specializing in the development of advanced medical devices and technologies. The company has a long history in the research and development of medical implants and prosthetics but has quickly expanded into a broader range of medical applications. With its focus on developing innovative products for patients' quality of life, Advanced Biomedical Technologies Inc will continue to play an important role in medical innovation. Advanced Biomedical Technologies is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Advanced Biomedical Technologies's Liabilities

Advanced Biomedical Technologies's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Advanced Biomedical Technologies's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Advanced Biomedical Technologies's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Advanced Biomedical Technologies's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Advanced Biomedical Technologies’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Advanced Biomedical Technologies stock

The Liabilities of Advanced Biomedical Technologies is 7.87 M USD in 2026.

The Liabilities of Advanced Biomedical Technologies changed from 6.70 M USD to 7.87 M USD, representing a 17.54% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Advanced Biomedical Technologies since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Advanced Biomedical Technologies historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Advanced Biomedical Technologies

All Key Metrics — Advanced Biomedical Technologies